Work

The Global Portfolio of New Antimalarial Medicines Under Development

Year: 2009

Type: review

Abstract: With the elimination of malaria now considered a realistic goal, it would be useful for scientists and policy makers to have an inventory of the arsenal of antimalarials, current and prospective, that could help make this goal a reality. In order to provide an overview of antimalarial projects in recent clinical development, we review here the global portfolio of antimalarial drugs in clinical phases of development complemented by projects in the preclinical and early discovery phases. The portfolio is discussed in terms of the novelty of the new molecules and their potential health impact in terms of addressing the requirements for the control and eventual eradication of malaria.

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1038/clpt.2009.51

Authors: P Olliaro, TNC Wells

Institutions: University of Oxford, World Health Organization, Special Programme for Research and Training in Tropical Diseases, Medicines for Malaria Venture

Language: English

Topic: Malaria Research and Control

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Drugs for Neglected Diseases initiative